SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples quarterly earnings beat expectations, led by iPhone and Mac sales, but misses in China, iPad and wearablesand a margin boost from tariff refundsleft investors debating the quality of the results and the outlook. Despite the beat, the stocks muted reaction drew criticism over its valuation and growth prospects, while some traders saw the quarter as solid and awaited further management commentary.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs quarterly results and raised outlook dominate discussion: traders cite a strong beat and accelerating commercial AI growth, but the muted-to-negative share reaction has fueled debate over whether high expectations made it a sell the news event. Bulls view the operating results as strong, while skeptics argue the valuation is stretched amid weakness in technology stocks.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp selloff ahead of its Q3 earnings report is being tied to a broader semiconductor pullback and investor reaction to Intels weak outlook, rather than a company-specific announcement. Traders are split over whether AMDs results and guidance can reassure investors about AI and data-center demand, with concerns about high valuation and further downside competing with dip-buying and expectations of strong growth.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A strong fiscal first-quarter earnings beat, raised FY2027 revenue outlook, and robust bookings tied to AI chip-testing demand are driving attention. Traders are praising the growth outlook but debating the stocks rich valuation and questioning why shares are falling despite the results, with some blaming weakness across the broader market.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure as technology and AI-linked stocks sell off, with traders questioning whether heavy AI spending will generate returns sufficient to justify it; election and geopolitical uncertainty are also adding to volatility. The community is split between expecting further losses and viewing the pullback near major technical support as a potential buying opportunity.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

A report that nonprofit Usona may have submitted an FDA application for psilocybin in major depressive disorder has raised competitive concerns and coincided with a sharp selloff in CMPS. Traders dispute how much of a threat it poses, noting COMPASS targets treatment-resistant depression and questioning whether Usonas filing is confirmed, while awaiting an update on COMPASSs own NDA timeline.

Fabrinet engages in the provision of optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers (OEMs). The firm's services include process design and engineering, advanced optical packaging, printed circuit board assembly and test, new product introduction, supply chain and inventory management, and customized glass and crystal optics fabrication. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinets earnings beat and stronger outlook are driving attention, reinforcing optimism about demand for optical hardware used in AI data centers. Traders praised the results but debated the stocks weak, volatile reaction and whether strong fundamentals can overcome selling pressure.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A steep selloff in semiconductor and AI-related stocks has driven attention to SOXL, with traders citing concerns about an AI-sector correction, weakness in chip holdings, and uncertainty around upcoming earnings; the funds 3x leverage has intensified the swings. The community is split between expecting more losses and viewing the drop as an oversold buying opportunity, while some warn that leverage decay makes holding for a recovery especially risky.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON is drawing attention after its Q3 earnings report: traders cite the EPS beat and solid results, but debate whether broadly in-line guidance and the Ferric acquisition are weighing on the shares. Some see the deal as a near-term concern with potential longer-term benefits.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reached its prespecified 80th event, triggering final analysis and putting the GPS topline readout in focus. Traders are divided over the sharp selloff since the milestone: some see profit-taking or short-term trading pressure ahead of results and are holding, while others worry the price action signals distribution or trial risk; the results remain unknown.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ardent Health Appoints Gaurav Khanna as Chief Digital & Information Officer

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Gaurav Khanna as chief digital & information officer. In this role, Khanna will lead Ardent's technology, data, AI and digital strategy to support...

Ardent Health Announces Third Quarter 2026 Results Conference Call and Webcast Date

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2026 results after the market closes on Wednesday, Nov. 4, 2026. A conference call will be held the following day, Thursday, Nov...

The University of Kansas Health System and Ardent Health Announce Plans to Transition Ownership of St. Francis Campus

The University of Kansas Health System and Ardent Health (NYSE: ARDT) announced the signing of a definitive agreement today for The University of Kansas Health System to acquire full ownership of St. Francis Campus and affiliated care locations in Topeka, following a successful joint venture...

Is the Options Market Predicting a Spike in Ardent Health Stock?

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Ardent Health Hospitals Earn Recognition in U.S. News & World Reports 2026-2027 Best Hospitals Rankings

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that 13 hospitals across its network earned recognition in U.S. News & World Reports 2026-2027 Best Hospitals rankings, the publications 37th annual assessment of...

HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)

HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today defined the Enterprise Clinical Workforce Platform (ECWP), establishing a new enterprise category for healthcare built on a single, verified record for every clinician. For decades...

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler the first time...

Tuesday Sector Leaders: Hospital & Medical Practitioners, Cigarettes & Tobacco Stocks

In trading on Tuesday, hospital & medical practitioners shares were relative leaders, up on the day by about 1.8%. Leading the group were shares of Surgery Partners, up about 6.2% and shares of Ardent Health up about 3.8% on the day.

Also showing relative strength are ciga...

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, in Boston, Massachusetts. Members of the...

Implied Volatility Surging for Ardent Health Stock Options

Investors need to pay close attention to ARDT stock based on the movements in the options market lately. 

Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.

Ardent Health Inc.

US Election 2024: BoFA Securities Revamps Ratings On Humana, UHS, Ardent, Oscar Health Stocks After Trump Win

Equity

Neutral Sentiment

Following Donald Trump’s election win, Bank of America (BoFA)&nbsp;Securities updated its ratings on several healthcare stocks, according to thefly.com, indicating a mixed outlook for the sector under the new administration.&nbsp;Trump’s policies are anticipated to reshape healthcare, potentially easing regulatory pressures on Medicare Advantage providers like Humana, while casting uncertainties on other healthcare areas.THE UPSIDEBoFA&nbsp;Securities upgraded Humana (<a class="mention" data-mention="$HUM" data-symbol-id="HUM" href="https://stocktwits.com/symbol/HUM" target="_blank">$HUM</a>) from ‘Underperform’ to ‘Neutral,’ raising its price target from $247 to $308. Analysts see “dramatically improved” risk-reward dynamics for Humana, driven by potential for stronger reimbursement rates and diminished scrutiny on quality ratings and antitrust issues.&nbsp;These factors could offer a pathway for stock appreciation, particularly as regulatory pressures ease.&nbsp;Speculation is also mounting regarding a possible acquisition by Cigna ($CI) — rumored to be in pursuit of Humana.&nbsp;With anticipated softer antitrust oversight under a Trump-led administration, BoFA suggests the likelihood of an acquisition has increased, providing additional valuation support for HUM.&nbsp;Humana shares surged nearly 10% by Wednesday afternoon, with Stocktwits retail sentiment holding steady at ‘neutral.’<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/HUM_sentiment_and_message_volume_Nov_6_4fa9591bab.png" alt="HUM sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>HUM sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure>STAYING CAUTIOUSBoFA downgraded Universal Health Services (<a class="mention" data-mention="$UHS" data-symbol-id="UHS" href="https://stocktwits.com/symbol/UHS" target="_blank">$UHS</a>) and Ardent Health Services (<a class="mention" data-mention="$ARDT" data-symbol-id="ARDT" href="https://stocktwits.com/symbol/ARDT" target="_blank">$ARDT</a>) to ‘Neutral’ from ‘Buy,’ citing concerns about the impact of Trump’s win on Medicaid supplemental payments and health exchanges.&nbsp;The brokerage slashed UHS’s target from $259 to $223 and ARDT’s from $22 to $19, suggesting the current healthcare environment could become unfavorable for hospitals and healthcare facilities.&nbsp;UHS fell over 4% in Wednesday afternoon trading with retail sentiment at ‘neutral,’ while ARDT dropped more than 9% with retail sentiment marked as ‘extremely bullish.’<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/UHS_sentiment_and_message_volume_Nov_6_e469989915.png" alt="UHS sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>UHS sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure><figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ARDT_sentiment_and_message_volume_Nov_6_727743fabb.png" alt="ARDT sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>ARDT sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure>RED FLAG?On Oscar Health (<a class="mention" data-mention="$OSCR" data-symbol-id="OSCR" href="https://stocktwits.com/symbol/OSCR" target="_blank">$OSCR</a>), BoFA downgraded the stock to ‘Underperform’ from ‘Neutral,’ lowering its price target from $21 to $13.50.&nbsp;BoFA argues that the Trump administration’s stance will likely result in reduced support for exchange subsidies — the financial assistance provided to individuals and families who purchase health insurance through the Affordable Care Act (ACA) — creating significant headwinds for Oscar Health.&nbsp;Lowering its 2027 EPS estimate by to $0.85 (60% below consensus), BoFA foresees valuation pressure as Congress revisits subsidy policies and as enrollment peaks in 2026.&nbsp;The brokerage sees some near-term strength on quarterly results but “expects valuation to be capped as one approaches the subsidy debate in congress and enrollment cliff in 2026.”OSCR shares plummeted over 14% Wednesday, with retail sentiment plunging to ‘extremely bearish’ — the lowest level recorded this year.<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/OSCR_sentiment_and_message_volume_Nov_6_ce215fc2e9.png" alt="OSCR sentiment and message volume Nov 6.png" width="1314" height="320"><figcaption>OSCR sentiment and message volume Nov 6 as of 1:30 pm ET | source: Stocktwits</figcaption></figure>For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-election-2024-why-bank-stocks-are-rising-after-trump-victory/cJ4RCBjR9x">US Election 2024: Here’s Why Bank Stocks Are Rising After Trump's Victory</a>

BoFA downgraded Universal Health Services ($UHS) and Ardent Health Services ($ARDT) to ‘Neutral’ from ‘Buy,’ citing concerns about the impact of Trump’s win on Medicaid supplemental payments and health exchanges.

While Trump’s stance may benefit Medicare providers by pushing for higher rates and easing regulatory scrutiny, hospital operators face a challenging landscape under his proposed policies.

BoFA Securities Revamps Ratings On Humana, UHS, Ardent, Oscar Health Stocks After Trump Win: Are Retail Investors On Board?

Ardent Health Partners

Humana Inc

Oscar Health Inc - Ordinary Shares - Class A

Universal Health Services, Inc. - Ordinary Shares - Class B

Up more than 3%

Flat to up 3%

Flat to down 3%

Down more than 3%

What’s your expected total return for the S&amp;P 500 ($SPY) in November?

Stocktwits

What’s your expected total return for the S&P 500 (

Current Price	$11.73
Prev Close	$12.03
Open	$12.14
Dividend Yield	0.00%
50-Day Moving Average	$11.16
Beta	0.56
Avg. Volume	448,765.51
PE Ratio	21.90

52-Week High	$14.99
52-Week Low	$7.71
Market Capitalization	$1.7B
EPS (Annual)	$0.9601
Price to Book	1.26
Revenue Per Employee	$250,965.83

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARDT Fundamentals